Correlation Between Eledon Pharmaceuticals and Defence Therapeutics

Can any of the company-specific risk be diversified away by investing in both Eledon Pharmaceuticals and Defence Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Eledon Pharmaceuticals and Defence Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Eledon Pharmaceuticals and Defence Therapeutics, you can compare the effects of market volatilities on Eledon Pharmaceuticals and Defence Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Eledon Pharmaceuticals with a short position of Defence Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Eledon Pharmaceuticals and Defence Therapeutics.

Diversification Opportunities for Eledon Pharmaceuticals and Defence Therapeutics

-0.29

Correlation Coefficient

Eledon Pharmaceuticals  Defence Therapeutics

Very good diversification

The 3 months correlation between Eledon and Defence is -0.29. Overlapping area represents the amount of risk that can be diversified away by holding Eledon Pharmaceuticals and Defence Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Defence Therapeutics and Eledon Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Eledon Pharmaceuticals are associated (or correlated) with Defence Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Defence Therapeutics has no effect on the direction of Eledon Pharmaceuticals i.e., Eledon Pharmaceuticals and Defence Therapeutics go up and down completely randomly.

Pair Corralation between Eledon Pharmaceuticals and Defence Therapeutics

Given the investment horizon of 90 days Eledon Pharmaceuticals is expected to under-perform the Defence Therapeutics. But the stock apears to be less risky and, when comparing its historical volatility, Eledon Pharmaceuticals is 3.44 times less risky than Defence Therapeutics. The stock trades about -0.11 of its potential returns per unit of risk. The Defence Therapeutics is currently generating about 0.22 of returns per unit of risk over similar time horizon. If you would invest  27.00  in Defence Therapeutics on December 26, 2024 and sell it today you would earn a total of  73.00  from holding Defence Therapeutics or generate 270.37% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	98.39%
Values	Daily Returns

Eledon Pharmaceuticals  vs.  Defence Therapeutics

Eledon Pharmaceuticals

Risk-Adjusted Performance

Very Weak

Over the last 90 days Eledon Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's fundamental indicators remain very healthy which may send shares a bit higher in April 2025. The recent disarray may also be a sign of long period up-swing for the firm investors.

Defence Therapeutics

Risk-Adjusted Performance

Solid

Compared to the overall equity markets, risk-adjusted returns on investments in Defence Therapeutics are ranked lower than 17 (%) of all global equities and portfolios over the last 90 days. Despite nearly weak technical and fundamental indicators, Defence Therapeutics reported solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Eledon Pharmaceuticals and Defence Therapeutics

The main advantage of trading using opposite Eledon Pharmaceuticals and Defence Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Eledon Pharmaceuticals position performs unexpectedly, Defence Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Defence Therapeutics will offset losses from the drop in Defence Therapeutics' long position.

The idea behind Eledon Pharmaceuticals and Defence Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Competition Analyzer module to analyze and compare many basic indicators for a group of related or unrelated entities.